Compare SVRA & DCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SVRA | DCH |
|---|---|---|
| Founded | 2007 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.7B |
| IPO Year | 2009 | N/A |
| Metric | SVRA | DCH |
|---|---|---|
| Price | $5.04 | $5.36 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | $7.33 | ★ $11.67 |
| AVG Volume (30 Days) | 1.3M | ★ 4.6M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $82.74 |
| Revenue Next Year | $776.35 | $4.72 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.89 | $5.16 |
| 52 Week High | $7.01 | $8.75 |
| Indicator | SVRA | DCH |
|---|---|---|
| Relative Strength Index (RSI) | 36.84 | 23.59 |
| Support Level | $3.36 | $5.27 |
| Resistance Level | $6.10 | $5.96 |
| Average True Range (ATR) | 0.26 | 0.29 |
| MACD | -0.06 | -0.00 |
| Stochastic Oscillator | 6.69 | 13.09 |
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
Dauch Corp is a world-wide Tier 1 Automotive Supplier, Dauch designs, engineers and manufactures Driveline and Metal Forming technologies to support electric, hybrid and internal combustion vehicles.